glp 1 with crohn's disease Relevance of Glucagon-Like Peptide (GLP-1) in Inflammatory Bowel Diseases: A Narrative Review Heavy arch: from inflammatory bowel

Updated for 2026 with CMS-0057-F rule, Medicare GLP-1 Bridge program, MFN pricing deals, oral Wegovy approval, and AHIP reform pledges.

The booming GLP-1 market, projected to reach $167bn by 2031, presents compelling opportunities for private equity players to carve out their niche and capture substantial value, despite industry giants Novo Nordisk and Eli Lilly dominating the lions share of the market. Download PDF

Using ADHD drugs when you dont have it may make you work morebut less successfully.

KEY FACTS -MASH is on the rise due to rising levels of obesity and T2DM

In true GNC fashion, we led the industry by doing what weve always done best: helping consumers live well through education, innovation, and trusted wellness solutions